Asubio US History
| 1999 | Suntory Pharmaceutical, Inc. founded as an early stage clinical development company in Fort Lee, New Jersey.
............................................. |
| 1999 | Initiated the clinical development of Carperitide
in acute respiratory distress syndrome.
............................................. |
| 2000 | Initiated the clinical development of Piclozotan for the treatment of acute
ischemic stroke.
............................................. |
| 2002 | Initiated the clinical development of SUN N8075 as a neuroprotectant.
............................................. |
| 2004 | Change of company name to Daiichi Asubio Pharmaceuticals, Inc.
............................................. |
| 2004 | Moved offices to current location in Rochelle Park, NJ.
............................................. |
| 2005 | Initiated the clinical development of SUN11031 for the treatment of cachexia.
............................................. |
| 2006 | Initiated the clinical development of SUN13834 for the treatment of atopic dermatitis.
............................................. |
| 2006 | Initiated the clinical development of SUNN4057 for the treatment of Parkinson's Disease.
............................................. |
| 2007 | Change of company name to Asubio Pharmaceuticals, Inc.
............................................. |
| 2008 | Proof of concept study completed for SUNN4057 for Parkinson's Disease.
............................................. |
| 2009 | Proof of concept study completed for SUN13834 for atopic dermatitis.
............................................. |
| 2010 | Proof of concept study completed for SUN11031 for cachexia. |
| Back To top |